search icon
vivo-img

Meridian Bioscience Inc Share Price

VIVO
NASDAQ
$2.06
+$0.17
(8.99%)
1D
Industry: Health Care Equipment & Supplies Sector: Health Care

Meridian Bioscience Inc Analyst Forecast

Meridian Bioscience Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$1.49B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
35.3854
Volume info-icon
This is the total number of shares traded during the most recent trading day.
707.16K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.23

About Meridian Bioscience Inc, Common Stock

Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, including real-time PCR amplification under the Revogene brand; isothermal DNA amplification under the Alethia brand; lateral flow immunoassay using fluorescent chemistry under the Curian brand; rapid immunoassay under the ImmunoCard and ImmunoCard STAT! brands; enzyme-linked immunoassays under the PREMIER brand; anodic stripping voltammetry under the LeadCare brands; and urea breath testing for H. pylori under the BreathID and BreathTek brand. This segment also offers respiratory illness assays, such as tests for Group A strep, mycoplasma pneumonia, influenza, and pertussis; and blood chemistry products for LeadCare test kits for the detection of lead in blood. It sells products through direct sales force and independent distributors to acute care hospitals, reference laboratories, outpatient clinics, and physician office laboratories. The Life Science segment offers bulk antigens, antibodies, PCR/qPCR reagents, isothermal reagents, nucleotides, and bioresearch reagents used by in vitro diagnostic manufacturers, as well as researchers in immunological and molecular tests for human, animal, plant, and environmental applications. Meridian Bioscience, Inc. was incorporated in 1976 and is headquartered in Cincinnati, Ohio. more

Industry: Health Care Equipment & SuppliesSector: Health Care

Meridian Bioscience Inc Stock Returns

Time FrameVIVOSectorS&P500
1-Week Return--1.4%-1.21%
1-Month Return--4.04%-2.04%
3-Month Return--1.81%-0.35%
6-Month Return-10.07%1.5%
1-Year Return-2.89%17.99%
3-Year Return-19.98%70.94%
5-Year Return-91.77%31.43%68.43%
10-Year Return-90.17%127.77%227.66%

Meridian Bioscience Inc Financials

Sep '18Sep '19Sep '20Sep '21Sep '225YR TREND
Total Revenue213.57M201.01M253.67M317.90M333.02M[{"date":"2018-09-30","value":64.13,"profit":true},{"date":"2019-09-30","value":60.36,"profit":true},{"date":"2020-09-30","value":76.17,"profit":true},{"date":"2021-09-30","value":95.46,"profit":true},{"date":"2022-09-30","value":100,"profit":true}]
Cost of Revenue83.11M82.69M97.42M116.75M144.66M[{"date":"2018-09-30","value":57.45,"profit":true},{"date":"2019-09-30","value":57.16,"profit":true},{"date":"2020-09-30","value":67.34,"profit":true},{"date":"2021-09-30","value":80.7,"profit":true},{"date":"2022-09-30","value":100,"profit":true}]
Gross Profit130.46M118.33M156.25M201.15M188.36M[{"date":"2018-09-30","value":64.86,"profit":true},{"date":"2019-09-30","value":58.82,"profit":true},{"date":"2020-09-30","value":77.68,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":93.64,"profit":true}]
Gross Margin61.09%58.86%61.60%63.27%56.56%[{"date":"2018-09-30","value":96.54,"profit":true},{"date":"2019-09-30","value":93.03,"profit":true},{"date":"2020-09-30","value":97.35,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":89.39,"profit":true}]
Operating Expenses85.83M80.98M96.64M107.63M112.41M[{"date":"2018-09-30","value":76.35,"profit":true},{"date":"2019-09-30","value":72.04,"profit":true},{"date":"2020-09-30","value":85.97,"profit":true},{"date":"2021-09-30","value":95.75,"profit":true},{"date":"2022-09-30","value":100,"profit":true}]
Operating Income31.58M32.70M61.32M93.03M54.39M[{"date":"2018-09-30","value":33.95,"profit":true},{"date":"2019-09-30","value":35.15,"profit":true},{"date":"2020-09-30","value":65.92,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":58.46,"profit":true}]
Total Non-Operating Income/Expense(2.31M)(2.41M)(4.52M)(4.46M)(1.25M)[{"date":"2018-09-30","value":-230600000,"profit":false},{"date":"2019-09-30","value":-240600000,"profit":false},{"date":"2020-09-30","value":-452100000,"profit":false},{"date":"2021-09-30","value":-446100000,"profit":false},{"date":"2022-09-30","value":-124600000,"profit":false}]
Pre-Tax Income30.38M31.56M59.29M90.45M54.32M[{"date":"2018-09-30","value":33.59,"profit":true},{"date":"2019-09-30","value":34.89,"profit":true},{"date":"2020-09-30","value":65.55,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":60.05,"profit":true}]
Income Taxes6.53M7.17M13.11M19.04M11.86M[{"date":"2018-09-30","value":34.29,"profit":true},{"date":"2019-09-30","value":37.68,"profit":true},{"date":"2020-09-30","value":68.82,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":62.27,"profit":true}]
Income After Taxes23.85M24.38M46.19M71.41M42.46M[{"date":"2018-09-30","value":33.4,"profit":true},{"date":"2019-09-30","value":34.15,"profit":true},{"date":"2020-09-30","value":64.68,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":59.46,"profit":true}]
Income From Continuous Operations23.85M24.38M46.19M71.41M42.46M[{"date":"2018-09-30","value":33.4,"profit":true},{"date":"2019-09-30","value":34.15,"profit":true},{"date":"2020-09-30","value":64.68,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":59.46,"profit":true}]
Income From Discontinued Operations-----[{"date":"2018-09-30","value":"-","profit":true},{"date":"2019-09-30","value":"-","profit":true},{"date":"2020-09-30","value":"-","profit":true},{"date":"2021-09-30","value":"-","profit":true},{"date":"2022-09-30","value":"-","profit":true}]
Net Income23.85M24.38M46.19M71.41M42.46M[{"date":"2018-09-30","value":33.4,"profit":true},{"date":"2019-09-30","value":34.15,"profit":true},{"date":"2020-09-30","value":64.68,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":59.46,"profit":true}]
EPS (Diluted)0.740.680.981.681.38[{"date":"2018-09-30","value":44.05,"profit":true},{"date":"2019-09-30","value":40.48,"profit":true},{"date":"2020-09-30","value":58.33,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":82.14,"profit":true}]

Meridian Bioscience Inc Ratios

Meridian Bioscience Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

VIVO
Cash Ratio 0.94
Current Ratio 2.56
Quick Ratio 1.64

Meridian Bioscience Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

VIVO
ROA (LTM) 10.35%
ROE (LTM) 12.19%

Meridian Bioscience Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

VIVO
Debt Ratio Lower is generally better. Negative is bad. 0.25
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.75

Meridian Bioscience Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

VIVO
Trailing PE 35.39
Forward PE 40.65
P/S (TTM) 4.35
P/B 3.92
Price/FCF NM
EV/R 4.18
EV/Ebitda 19.32
PEG 1.33

FAQs

What is Meridian Bioscience Inc share price today?

Meridian Bioscience Inc (VIVO) share price today is $2.06

Can Indians buy Meridian Bioscience Inc shares?

Yes, Indians can buy shares of Meridian Bioscience Inc (VIVO) on Vested. To buy from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in VIVO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Meridian Bioscience Inc be purchased?

Yes, you can purchase fractional shares of Meridian Bioscience Inc (VIVO) via the Vested app. You can start investing in Meridian Bioscience Inc (VIVO) with a minimum investment of $1.

How to invest in Meridian Bioscience Inc shares from India?

You can invest in shares of Meridian Bioscience Inc (VIVO) via Vested in three simple steps:

  • Click on Sign Up or Invest in VIVO stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Meridian Bioscience Inc shares
What is Meridian Bioscience Inc 52-week high and low stock price?

The 52-week high price of Meridian Bioscience Inc (VIVO) is $. The 52-week low price of Meridian Bioscience Inc (VIVO) is $.

What is Meridian Bioscience Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Meridian Bioscience Inc (VIVO) is 35.3854

What is Meridian Bioscience Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Meridian Bioscience Inc (VIVO) is 3.92

What is Meridian Bioscience Inc dividend yield?

The dividend yield of Meridian Bioscience Inc (VIVO) is 0.00%

What is the Market Cap of Meridian Bioscience Inc?

The market capitalization of Meridian Bioscience Inc (VIVO) is $1.49B

What is Meridian Bioscience Inc's stock symbol?

The stock symbol (or ticker) of Meridian Bioscience Inc is VIVO

How Can Investors Use Meridian Bioscience Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Meridian Bioscience Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Meridian Bioscience Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Meridian Bioscience Inc shares for Indian investors?

When investing in Meridian Bioscience Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Meridian Bioscience Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Meridian Bioscience Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Meridian Bioscience Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Meridian Bioscience Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top